Selective EP4 receptor agonists intended for treating osteoporosis
This invention is directed to the use of EP4 receptor selective prostaglandin agonists for the manufacture of a medicament for treating conditions which present with low bone mass, particularly osteoporosis, frailty, an osteoporotic fracture, a bone defect, childhood idiopathic bone loss, alveolar b...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | cze ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KE HUAZHU LEFKER BRUCE ALLEN CAMERON KIMBERLY O KEEFE THOMPSON DAVID DUANE |
| description | This invention is directed to the use of EP4 receptor selective prostaglandin agonists for the manufacture of a medicament for treating conditions which present with low bone mass, particularly osteoporosis, frailty, an osteoporotic fracture, a bone defect, childhood idiopathic bone loss, alveolar bone loss, mandibular bone loss, bone fracture, osteotomy, bone loss associated with periodontitis, or prosthetic ingrowth. This invention is especially directed to a use wherein the EP4 receptor selective agonist is a compound of Formula I: wherein the variables are as defined in the specification.e |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CZ20022048A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CZ20022048A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CZ20022048A33</originalsourceid><addsrcrecordid>eNqNyjEKwkAQRuFtLES9w3gAYdmksDUhYiloZROWzZ-wEGaWncHza-EBrB58vK3rHliRLL9Bw72lioRiUikuwllNKbOBJ0w0f9UqomVeSNQgRapo1r3bzHFVHH7dueN1ePa3E4qM0BITGDb2r-B9CL49X5rmn-cDV5MybQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Selective EP4 receptor agonists intended for treating osteoporosis</title><source>esp@cenet</source><creator>KE HUAZHU ; LEFKER BRUCE ALLEN ; CAMERON KIMBERLY O KEEFE ; THOMPSON DAVID DUANE</creator><creatorcontrib>KE HUAZHU ; LEFKER BRUCE ALLEN ; CAMERON KIMBERLY O KEEFE ; THOMPSON DAVID DUANE</creatorcontrib><description>This invention is directed to the use of EP4 receptor selective prostaglandin agonists for the manufacture of a medicament for treating conditions which present with low bone mass, particularly osteoporosis, frailty, an osteoporotic fracture, a bone defect, childhood idiopathic bone loss, alveolar bone loss, mandibular bone loss, bone fracture, osteotomy, bone loss associated with periodontitis, or prosthetic ingrowth. This invention is especially directed to a use wherein the EP4 receptor selective agonist is a compound of Formula I: wherein the variables are as defined in the specification.e</description><edition>7</edition><language>cze ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040317&DB=EPODOC&CC=CZ&NR=20022048A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040317&DB=EPODOC&CC=CZ&NR=20022048A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KE HUAZHU</creatorcontrib><creatorcontrib>LEFKER BRUCE ALLEN</creatorcontrib><creatorcontrib>CAMERON KIMBERLY O KEEFE</creatorcontrib><creatorcontrib>THOMPSON DAVID DUANE</creatorcontrib><title>Selective EP4 receptor agonists intended for treating osteoporosis</title><description>This invention is directed to the use of EP4 receptor selective prostaglandin agonists for the manufacture of a medicament for treating conditions which present with low bone mass, particularly osteoporosis, frailty, an osteoporotic fracture, a bone defect, childhood idiopathic bone loss, alveolar bone loss, mandibular bone loss, bone fracture, osteotomy, bone loss associated with periodontitis, or prosthetic ingrowth. This invention is especially directed to a use wherein the EP4 receptor selective agonist is a compound of Formula I: wherein the variables are as defined in the specification.e</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEKwkAQRuFtLES9w3gAYdmksDUhYiloZROWzZ-wEGaWncHza-EBrB58vK3rHliRLL9Bw72lioRiUikuwllNKbOBJ0w0f9UqomVeSNQgRapo1r3bzHFVHH7dueN1ePa3E4qM0BITGDb2r-B9CL49X5rmn-cDV5MybQ</recordid><startdate>20040317</startdate><enddate>20040317</enddate><creator>KE HUAZHU</creator><creator>LEFKER BRUCE ALLEN</creator><creator>CAMERON KIMBERLY O KEEFE</creator><creator>THOMPSON DAVID DUANE</creator><scope>EVB</scope></search><sort><creationdate>20040317</creationdate><title>Selective EP4 receptor agonists intended for treating osteoporosis</title><author>KE HUAZHU ; LEFKER BRUCE ALLEN ; CAMERON KIMBERLY O KEEFE ; THOMPSON DAVID DUANE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CZ20022048A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>cze ; eng</language><creationdate>2004</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>KE HUAZHU</creatorcontrib><creatorcontrib>LEFKER BRUCE ALLEN</creatorcontrib><creatorcontrib>CAMERON KIMBERLY O KEEFE</creatorcontrib><creatorcontrib>THOMPSON DAVID DUANE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KE HUAZHU</au><au>LEFKER BRUCE ALLEN</au><au>CAMERON KIMBERLY O KEEFE</au><au>THOMPSON DAVID DUANE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Selective EP4 receptor agonists intended for treating osteoporosis</title><date>2004-03-17</date><risdate>2004</risdate><abstract>This invention is directed to the use of EP4 receptor selective prostaglandin agonists for the manufacture of a medicament for treating conditions which present with low bone mass, particularly osteoporosis, frailty, an osteoporotic fracture, a bone defect, childhood idiopathic bone loss, alveolar bone loss, mandibular bone loss, bone fracture, osteotomy, bone loss associated with periodontitis, or prosthetic ingrowth. This invention is especially directed to a use wherein the EP4 receptor selective agonist is a compound of Formula I: wherein the variables are as defined in the specification.e</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | cze ; eng |
| recordid | cdi_epo_espacenet_CZ20022048A3 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Selective EP4 receptor agonists intended for treating osteoporosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T10%3A28%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KE%20HUAZHU&rft.date=2004-03-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECZ20022048A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |